Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
389
datasets available to search
ShareScore release 0.9.0
Dataset results
389 results for “Acute myeloid leukemia (AML)”
A Study of ASP2215 Versus Salvage Chemotherapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-like Tyrosine Kinase (FLT3) Mutation
ClinicalTrials.gov study NCT02421939. IPD Sharing: YES. Countries: 14. Publications: 4.
Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT01074047. IPD Sharing: Not stated. Countries: 18. Publications: 2.
An Efficacy and Safety Study of Decitabine (DACOGEN) Plus Talacotuzumab (JNJ-56022473; Anti CD123) Versus Decitabine (DACOGEN) Alone in Participants With Acute Myeloid Leukemia (AML) Ineligible for In
ClinicalTrials.gov study NCT02472145. IPD Sharing: Not stated. Countries: 14. Publications: 1.
Phase 1-2 of Azacitidine + Lenalidomide for Previously Untreated Elderly Patients With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT00890929. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Clofarabine vs Clofarabine in Plus With Low-Dose Ara-C in Previously Untreated Patients With Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndromes (MDS).
ClinicalTrials.gov study NCT00088218. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Sorafenib Plus 5-Azacitidine Initial Therapy of Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MS) With FLT3-ITD Mutation
ClinicalTrials.gov study NCT02196857. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Clinical Trial of Oral Ciprofloxacin and Etoposide in Subjects With Resistant Acute Myeloid Leukemia (AML)(UF-AML-CE-101)
ClinicalTrials.gov study NCT02773732. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of the Effectiveness of Venetoclax in Combination With Azacitidine or Decitabine in an Outpatient Setting in Patients With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy
ClinicalTrials.gov study NCT03941964. IPD Sharing: YES. Countries: 1. Publications: 1.
Efficacy and Pharmacogenomics of Cladribine Based Salvage Chemotherapy in Patients with Relapse/Refractory and Secondary Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT03150004. IPD Sharing: NO. Countries: 1. Publications: 2.
Study of Idarubicin, Cytarabine, and Nivolumab in Patients With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT02464657. IPD Sharing: Not stated. Countries: 1. Publications: 1.
LBH589 Plus Decitabine for Myelodysplastic Syndromes (MDS) or Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT00691938. IPD Sharing: Not stated. Countries: 1. Publications: 1.
APR-246 in Combination With Azacitidine for TP53 Mutated AML (Acute Myeloid Leukemia) or MDS (Myelodysplastic Syndromes) Following Allogeneic Stem Cell Transplant
ClinicalTrials.gov study NCT03931291. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Onvansertib in Combination With Either Low-dose Cytarabine or Decitabine in Adult Patients With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT03303339. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Efficacy of Oral Azacitidine Plus Best Supportive Care as Maintenance Therapy in Subjects With Acute Myeloid Leukemia (AML) in Complete Remission
ClinicalTrials.gov study NCT01757535. IPD Sharing: Not stated. Countries: 23. Publications: 8.
Study to Investigate the Safety and Clinical Activity of GSK3326595 and Other Agents to Treat Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT03614728. IPD Sharing: YES. Countries: 2. Publications: 1.
Study of Obatoclax in Previously Untreated Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT00684918. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Safety and Efficacy of 72-hour and 120-hour Infusion of Rigosertib in Acute Myeloid Leukemia (AML) and Acute Lymphoid Leukemia (ALL)
ClinicalTrials.gov study NCT01167166. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Decitabine and Plerixafor in Elderly Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT01352650. IPD Sharing: NO. Countries: 1. Publications: 2.
Atovaquone (Mepron®) Combined With Conventional Chemotherapy for de Novo Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT03568994. IPD Sharing: NO. Countries: 1. Publications: 1.
WT1 Peptide Vaccination in Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT00153582. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.